| |
| Trade Name | Reclaim DBS Therapy for Obsessive Compulsive Disorder (CCD) System |
| Classification Name | deep brain stimulator for obsessive compulsive disorder (ocd) |
| Generic Name | deep brain stimulator for obsessive compulsive disorder (ocd) |
| Applicant |
| Medtronic Inc.,Neurological Division. |
| 7000 central ave., northeast |
| minneapolis, MN 55432 |
|
| HDE Number | H050003 |
| Supplement Number | S259 |
| Date Received | 02/23/2021 |
| Decision Date | 05/07/2021 |
| Product Code | |
| Advisory Committee |
Neurology |
| Supplement Type | normal 75 day track |
| Supplement Reason | change design/components/specifications/material |
| Expedited Review Granted? | No |
| Combination Product | No |
Approval Order Statement Approval for software changes to the medtronic model a620 patient programmer application (ppa) which consist of 1) fixing a defect that prevents the software from communicating with certain model b35200 inss that have tel-m ids containing particular values, 2) updating the impedance test that is used to support the mri eligibility feature of the a620 ppa, and 3) other minor changes and bug fixes. |